Source: Virtual Congress 2021 – COVID - 19 risk predictions



Rating:

Share or cite this content

Citations should be made in the following way:
O. Myronenko (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), O. Plekhanova (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine). Severity or risk of progression: what does serum ferritin really reflect in COVID-19 pneumonia?. 3656

Member's Comments

No comment yet.

Related content which might interest you: Severity, risk of progression or thrombosis – what does the D-dimer really reflect in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia Year: 2011 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 Measurement of serum total antioxidant status in patients with community acquired pneumonia: correlation with the severity of the disease Source: Eur Respir J 2002; 20: Suppl. 38, 283s Year: 2002 The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia? Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017 Year: 2017 Level of serum procalcitonin and pneumonia risk classes Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Elevated creatinine is a sensitive severity marker in community acquired pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Late Breaking Abstract - Dysbiosis in the lung microbiome of patients with HIV and pneumonia is associated with worse disease severity and mortality scores Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Total serum bilirubin levels are not related to the severity of COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Correlation between fever and clinical severity in bronchiolitis - is there an influence of associated risk factors? Source: Annual Congress 2004 - Viral bronchiolitis in children: what's new in diagnosis and treatment? Year: 2004 Late-breaking abstract: Evaluation of CRP, PCT, clinical pulmonary infection score and pneumonia severity scores for the diagnosis and prognosis of nursing home acquired pneumonia Source: Annual Congress 2011 - Early diagnosis in primary care Year: 2011 Prognostic value of procalcitonin in community-acquired pneumonia Source: Eur Respir J 2011; 37: 384 Year: 2011 Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016